H2 receptor blocker, also known as H2 receptor antagonist, is a class of drugs mostly used to treat and inhibit duodenal ulcers. Additionally, it is used for the treatment of gastric ulcers and for conditions such as Zollinger-Ellison disease, in which excessive acid is secreted by the stomach. H2 receptor effectively works to reduce acid reflux or GERD (gastro-esophageal reflux disease). These drugs are available as over the counter (OTC) as well as with registered medical prescription.

The global H2-receptor blocker market is segmented on the basis of drug class, dosage form, application, and distribution channel. Based on the drug class, the market is segmented into famotidine, cimetidine, ranitidine, and nizatidine which are all widely used medicines as H2- receptor antagonist. Based on the dosage form, the market is segmented into tablet, powder, suspension, and syrup. Depending on application, the H2- receptor blocker market is segmented into gastritis, peptic ulcers, Zollinger-Ellison Syndrome, allergies and acid reflux agents. Based on the distribution channel, the market is segmented into hospital pharmacies, retail pharmacies, and online pharmacies.

Major drivers associated with global H2 receptor blocker market include rising prevalence and rising incidence of medical conditions such as inflamed stomach, gastro-esopheagal reflux disease, duodenal and gastric ulcers  Additionally, the factor contributing to significant growth of the global H2 receptor blocker market is the increasing number of generic manufacturers for drugs. Rising prevalence of peptic ulcer and stress induced ulcer due to changes in diet and day to day lifestyle may increase the demand for H2-receptor antagonist which is anticipated to enhance the growth of global market.

To propel the market growth during the forecast period, the major strategy acquired by H2-receptor blocker market players include to focus on R&D of the product portfolio. To meet the increasing demand of market and deliver high-quality, non-adulterated drugs with improved dosage form and assemble innovative techniques owing to the sequential expansion of global H2 receptor blocker marketl.

Market Coverage

• The market number available for – 2020-2027
• Base year- 2020
• Forecast period- 2021-2027
• Segment Covered- 

o By Drug Class

o By Dosage Form

o By Application

o By Distribution Channel

• Competitive Landscape- GSK, Medochemie, Horizon Pharma, ZAFA Pharmaceutical, Merck, Incepta Pharmaceuticals Ltd., Brotannica.

Key questions addressed by the report

• What is the market growth rate?
• Which segment and region dominates the market in base year?
• Which segment and region will project fastest growth in the market?
• How COVID-19 impacted the market?

o Recovery Timeline

o Deviation from pre-COVID forecast

o Most affected region and segment

• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?

Global H2 Receptor Blocker Market Report Segments

By Drug Class

o Famotidine

o Cimetidine

o Ranitidine 

o Nizatidine

By Dosage Form 

o Tablet

o Powder

o Syrup

o Suspension

o Others 

By Application 

o Gastritis

o Peptic Ulcers

o Zollinger-Ellison Syndrome

o Allergies

o Others

By Distribution Channel 

o Hospital Pharmacies

o Retail Pharmacies

o Online Pharmacies

Global H2-Receptor Blocker Market Report Segment by Region